Browse articles from EyeWorld.org related to IOLs. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
While laser vision correction and IOL exchange remain the preferred methods for correcting residual refractive error, two ophthalmologists said there is still a place for piggyback IOLs. They spoke about when they would consider a piggyback IOL, their preferred lenses, and their thoughts on newer generation IOL options.
➤ Priority review granted to possible LHON treatment ➤ Update on drug in development for neuropathic corneal pain ➤ FDA approves generic bimatoprost ➤ Phase 1/2a clinical results for first-in-human retinal pigment epithelial stem cell therapy ➤ Adult dosing complete in trial for X-linked retinoschisis therapy ➤ Company news ➤ ASCRS news and events
In this YES Connect column, two surgeons described their techniques for how and when to successfully fixate a secondary lens when the capsule is either not present or not secure enough for traditional IOL implantation.
➤ FDA approves aceclidine-based drop for presbyopia ➤ Long-term data supports efficacy of continuous wet AMD treatment ➤ First patient dosed in trial for drug eluting lacrimal canaliculus plug ➤ Acquisition news ➤ ASCRS news and events
Manual marking, digital marking, manual and digital marking—toric IOL alignment methods continue to be an important topic. Both methods still have a place, and both have their pros and cons. Four physicians discussed their preferences.
➤ Fast Track designation granted to one-time intravitreal gene therapy for geographic atrophy ➤ FDA clears IND for Stargardt gene therapy to move forward into a Phase 1/2 clinical trial ➤ BLA submission for retinitis pigmentosa gene therapy begins ➤ First patient dosed in Phase 1/2 trial evaluating NK therapy ➤ Enrollment complete in Phase 2b trial for PCED therapy ➤ ASCRS news and events
The University of Chicago ophthalmology residents reviewed “Comparative evaluation of clinical results and patient-reported outcomes of enhanced monofocal and conventional monofocal intraocular lenses” from the Journal of Cataract & Refractive Surgery.
Since its approval, the Light Adjustable Lens (LAL, RxSight) has become well known for the successful outcomes that it can provide for patients. Four ophthalmologists shared their experience with the product and what they’ve learned about limitations, how to work through challenges, and more.
Ophthalmology is constantly evolving to meet new and unmet needs. EyeWorld asked members of its Cataract Editorial Board and the ASCRS Cataract Clinical Committee to weigh in on: If I could ask industry to produce one new product, this is what it would be and why.
Get the latest ophthalmology news delivered to your inbox every Friday.